Cancer Commons Report issue

Foundation

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Alternative names

Cancer Commons

Active Ingredients

Drugs in Other Trials (1)

bvd-523 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1